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Lymphoma is usually recognized as the third most frequent metastatic malignancy involving the heart. In
recent years, the incidence of cardiac lymphoma has increased, mainly because of HIV-infected
patients. We present a case of secondary cardiac lymphoma in an HIV patient presenting with heart
failure. Transthoracic echocardiography showed increased left ventricular (LV) wall thickness and an
extensive mass in the right cavities with involvement of the tricuspid annulus (Figure 1). Doppler
tissue imaging (DTI) showed reduced systolic and diastolic velocities at mitral and tricuspid annulus,
compatible with systolic and diastolic myocardial dysfunction, likely owing to infiltration. After 2
weeks of chemotherapy, repeated exam showed significant reduction of the tumour mass and of the
LV wall thickness, as well as normalized systolic and diastolic velocities at mitral and tricuspid
annulus, as assessed by DTI. Use of transthoracic echocardiography, mostly two-dimensional imaging,
has been described for several years for the diagnosis of cardiac involvement as well as for the assess-
ment of tumour regression in response to chemotherapy. The present case report highlights the poten-
tial utility of other echocardiographic modalities, particularly DTI, for the assessment of cardiac








When considering malignant tumours affecting the heart,
secondary malignancies are far more frequent than
primary tumours. Lymphoma is usually recognized as the
third most frequent metastatic malignancy involving the
heart, when considering absolute numbers (following lung
and breast carcinomas), being the second most frequent,
when considering relative incidence of metastasis (following
melanoma).1 Cardiac involvement by malignant lymphoma is
more common than usually assumed, with autopsy series
documenting cardiac involvement in nearly 20–25% of non-
Hodgkin lymphomas (NHL).2–4 Moreover, the incidence of
cardiac lymphomas has increased in recent years, mainly
because of HIV infection.5,6
Assessment of a cardiac lymphoma is usually based on
two-dimensional imaging evaluation. However, other echo-
cardiographic modalities, such as Doppler tissue imaging
(DTI), can offer additional information about potentially
infiltrative malignancies such as lymphoma.
We present a case of secondary cardiac lymphoma in an
HIV-infected patient.
Case report
A 68-year-old man was admitted with fatigue, shortness of
breath, and peripheral oedema with 1 week of evolution.
He also presented a 3-month history of postprandial fullness
and 40-kg weight loss in approximately 7 weeks. He was
known to be HIV-positive since 2002. In 2006 he was
started on antiretroviral therapy because of his low
CD4-positive lymphocyte count (112 CD4-positive lympho-
cytes per microlitre) and a high viral load (176 copies/mL).
He was also a diabetic (type 2) and had ulcerative collitis.
On physical examination, he presented muscle wasting,
with bilateral malleolar oedema and absence of breath
sounds in the lower half of the right hemithorax. His electro-
cardiogram showed sinus tachycardia with right axis
deviation, Sokolow-Lyon criteria for left ventricular (LV)
hypertrophy and T wave inversion in inferior leads. The
chest X-ray revealed pleural effusion on the right side. Cyto-
pathological examination of the fluid revealed 84% of
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nucleated cells to be atypical lymphoid cells, and immuno-
phenotypic characteristics suggested large B-cell NHL.
Transthoracic echocardiography showed increased LV wall
thickness and an extensive mass in the right cavities with
involvement of the tricuspid annulus (Figure 1A and B; see
Supplementary data online, Videos 1 and 2). LV systolic func-
tion was assessed using the ejection fraction (EF) calculation
by the modified Simpson’s rule approach (EF ¼ 50%) and
peak mitral annular systolic velocity (S0) determination
(S0 ¼ 4,87 cm/s) in the lateral area (Figure 2B). Integrating
both results, the patient had preserved EF but impaired LV
longitudinal systolic function as assessed by DTI. DTI also
demonstrated severe right ventricular (RV) function impair-
ment with a peak tricuspid annular systolic velocity (St) of
4.28 cm/s (Figure 2C). Inferior vena cava (IVC) appeared
dilated, with a respiratory variability of ,50%; minor tricus-
pid regurgitation allowed the estimation of pulmonary systo-
lic artery pressure (PSAP) in 50–55 mmHg. DTI revealed an
E/E0 ratio of 12, which was in accordance with moderate
diastolic dysfunction as assessed by pulse-wave Doppler of
the transmitral flow [pseudo-normal pattern (Figure 2A)],
pulmonary vein flow (systolic wave velocity inferior to
diastolic wave velocity), and mitral annulus DTI (reduced
annular velocities).
Transoesophageal echocardiography confirmed the pres-
ence of an extensive mass involving the right cavities and
the pericardium, with minimal pericardial effusion
(Figure 3A). A little mass was visualized in the right atrial
appendage (Figure 3B). Attending to its localization, differ-
ent echogenicity and mobility, it was considered consistent
with a thrombus. This finding, in addition to the clinical
picture, right-axis deviation on ECG, and transthoracic infor-
mation (namely RV dysfunction and pulmonary hyperten-
sion), raised the hypothesis of concomitant pulmonary
embolism. In addition, pulmonary embolism could have
been, at least partially, responsible for the reduction in
DTI velocities of the tricuspid annulus. A computed tomogra-
phy (CT) scan was promptly performed and discarded the
presence of pulmonary embolism. Cerebral, thoracic, and
abdominal CT scan confirmed that no other organ was
found to be involved by the lymphoma.
The patient was started on a chemotherapeutic regimen
with cyclophosphamide, vincristine, adriamycin, and predni-
solone associated to rituximab, a monoclonal antibody
Figure 1 First transthoracic echocardiogram; two-dimensional imaging of parasternal view (A) and apical four-chamber view (B) showing
increased left ventricular wall thickness and an extensive mass in the right cavities with involvement of the tricuspid annulus.
Figure 2 First transthoracic echocardiogram; pulse-wave Doppler of the transmitral flow (A) showing a pseudo-normal pattern; DTI at the
mitral annulus with reduced peak mitral annular systolic and diastolic velocities (S0 and E0) in the lateral area (B), as well as reduced peak
tricuspid annular systolic velocity (St) (C).
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against the protein CD 20. Oral anticoagulation was also
initiated, given the possible thrombus in the right atrial
appendage. Additional medical treatment consisted of
diuretics (furosemide and spironolactone), an angiotensin-
converting enzyme inhibitor, and oral anti-diabetic agents.
His clinical condition improved significantly 2 weeks later.
The new echocardiogram showed significant reduction of the
tumour mass and of the LV wall thickness (Figure 4A and B;
see Supplementary data online, Video 3). LVEF was normal
(EF ¼ 58%) and DTI revealed normalized mitral annulus vel-
ocity with S0 ¼ 8 cm/s (in the lateral area of the mitral
annulus) (Figure 5B). A significant improvement of right ven-
tricular systolic function was also evidenced by DTI with St ¼
11.9 cm/s (Figure 5C). In addition to the important
reduction in LV wall thickness, the echocardiographic exam
revealed improvement in diastolic function, with transmitral
flow showing relaxation anomaly and an E/E0 ratio of 4
(Figure 5A and B). A decrease in PSAP (40 mmHg) was
observed as well as a non-dilated IVC with normalized respir-
atory variability. These findings favoured the hypothesis of
an extensive infiltration of the left and right ventricles by
lymphoma cells with consequent impairment of LV and
right ventricular contractility and relaxation. Based on the
clinical and echocardiographic evolution of the patient,
the same chemotherapeutic regimen was maintained.
The patient’s treatment was completed after 4 months of
chemotherapy and he underwent another transthoracic
echocardiogram. No mass was visualized and the remaining
exam was unchanged when compared with the previous
one. On his last visit (8 months later), he was doing well
and there was no evidence of recurrence.
Discussion
As referred previously, the incidence of cardiac lymphomas
has considerably increased, mainly in HIV-infected
patients.5,6 It is the second most frequent malignancy in
HIV-infected patients, after Kaposi’s sarcoma.7,8 The inci-
dence of NHL among HIV-positive patients has been reported
to be 2.9%, a nearly 60 times higher incidence when com-
pared with general population.9,10
The clinical presentation of cardiac lymphoma can be
varied: heart failure, pericardial effusion, arrhythmias, or
on the opposite, no cardiac manifestations.5 The possibility
of cardiac involvement in patients with lymphoma should
always be considered, particularly in the presence of HIV
Figure 4 Transthoracic echocardiogram after 15 days of chemotherapy; two-dimensional imaging of parasternal view (A) and apical
four-chambers view (B) showing significant reduction of the tumour mass and also of the left ventricular wall thickness.
Figure 3 Transoesophageal echocardiography showing an extensive mass in the right cavities (A) and most likely a thrombus in the right
atrial appendage (B).
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infection.9 Cardiac lymphoma most commonly presents as a
nodular or polypoid mass with variable myocardial
infiltration.8
When assessing a cardiac lymphoma, two-dimensional
imaging allows the accurate evaluation and quantification
of masses and ventricular wall thickening. In addition,
Doppler study, particularly DTI, appears to be useful in asses-
sing myocardial impairment owing to infiltration. Klein
et al.11,12 demonstrated the correlation between Doppler-
filling patterns and the degree of amyloid infiltration as
measured by LV wall thickness, when evaluating cardiac amy-
loidosis. The existence of such correlation could be hypoth-
esized for the infiltrative component of cardiac lymphoma.
However, it should be noted that the ability of Doppler
study, namely E/E0, to predict LV-filling pressures in cardiac
lymphoma remains to be established. DTI was also very
useful to quantify RV systolic dysfunction in our patient
since other methods, such as tricuspid annular plane systolic
excursion (TAPSE), were unavailable because of marked ana-
tomical deformation of the tricuspid annulus.13
Besides allowing a better visualization of the cardiac mass
and its relationship with cardiac structures, transoesopha-
geal echocardiography allowed the distinction of a probable
thrombus, from the neoplasm, in the right atrial appendage.
Prognosis of HIV-associated cardiac NHL is generally poor.
Although clinical improvement and significant tumour
regression has been described with combination chemother-
apy, early post-chemotherapy death may occur in conse-
quence of massive pulmonary emboli, refractory heart
failure, and cardiac arrhythmias.7,14
In conclusion, this case highlights not only the utility of
echocardiography imaging, but also the potential utility of
its various modalities and techniques, such as two-
dimensional imaging, DTI, and transoesophageal echocardio-
graphy among others, to assess cardiac involvement by
lymphoma. Echocardiography imaging is also helpful to
monitor the response to the chemotherapeutic regimen insti-
tuted, and to define possible adjuvant therapies, such as
anticoagulation in the presence of concomitant thrombus.
Supplementary data
Supplementary data are available at European Journal of
Echocardiography online.
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Figure 5 Transthoracic echocardiography after 15 days of chemotherapy; pulse-wave Doppler of the transmitral flow (A) showing relaxation
anomaly; DTI at the mitral annulus with normalized peak mitral annular systolic and diastolic velocities (S0 and E0) in the lateral area (B), as
well as normalized peak tricuspid annular systolic velocity (St) (C).
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